Fig. 4From: The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapyLoco-regional (a), distant (b) and global (c) progression free survival and overall survival (d) according to early metabolic responseBack to article page